The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case-control - PubMed (original) (raw)
The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case-control
Samy Suissa. Epidemiology. 2015 Mar.
Abstract
Observational studies of drug effects conducted using health care mega-databases often involve large cohorts with multiple time-varying exposures and covariates. These present formidable technical challenges in data analysis, necessitating sampling approaches such as nested case-control designs. The nested case-control approach is, however, baffling to medical journal readers, particularly the comparisons involving "cases" versus "controls" and the convoluted way in which forward-looking relations from exposure to outcome are extracted from backward-looking data. I propose a "quasi-cohort" approach involving alternative ways of data presentation and analysis that are more in line with the underlying cohort design, including the computation of quasi-rates, rate ratios, and quasi-rate differences. I illustrate the quasi-cohort approach using data from a study of pneumonia risk associated with inhaled corticosteroid use in a cohort of 163,514 patients with chronic obstructive pulmonary disease, including 20,344 who had the outcome event of pneumonia hospitalization during more than 304 million person-days of follow-up.
Comment in
- Re: The Quasi-cohort Approach in Pharmaco epidemiology: Upgrading the Nested Case-control.
Tanaka S, Noma H. Tanaka S, et al. Epidemiology. 2016 Jan;27(1):e1. doi: 10.1097/EDE.0000000000000398. Epidemiology. 2016. PMID: 26426940 No abstract available.
Similar articles
- Re: The Quasi-cohort Approach in Pharmaco epidemiology: Upgrading the Nested Case-control.
Tanaka S, Noma H. Tanaka S, et al. Epidemiology. 2016 Jan;27(1):e1. doi: 10.1097/EDE.0000000000000398. Epidemiology. 2016. PMID: 26426940 No abstract available. - Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
Ernst P, Gonzalez AV, Brassard P, Suissa S. Ernst P, et al. Am J Respir Crit Care Med. 2007 Jul 15;176(2):162-6. doi: 10.1164/rccm.200611-1630OC. Epub 2007 Mar 30. Am J Respir Crit Care Med. 2007. PMID: 17400730 - Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Joo MJ, et al. Respir Med. 2010 Feb;104(2):246-52. doi: 10.1016/j.rmed.2009.10.002. Epub 2009 Oct 30. Respir Med. 2010. PMID: 19879745 - Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association.
Singanayagam A, Chalmers JD, Hill AT. Singanayagam A, et al. QJM. 2010 Jun;103(6):379-85. doi: 10.1093/qjmed/hcq023. Epub 2010 Mar 15. QJM. 2010. PMID: 20231237 Review. - The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA. Hanania NA. Pulm Pharmacol Ther. 2008;21(3):540-50. doi: 10.1016/j.pupt.2007.12.004. Epub 2008 Jan 6. Pulm Pharmacol Ther. 2008. PMID: 18280761 Review.
Cited by
- Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
Pottegård A, Friis S, Stürmer T, Hallas J, Bahmanyar S. Pottegård A, et al. Basic Clin Pharmacol Toxicol. 2018 May;122(5):451-459. doi: 10.1111/bcpt.12946. Epub 2018 Jan 15. Basic Clin Pharmacol Toxicol. 2018. PMID: 29265740 Free PMC article. Review. - Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration.
Lee H, Jeon HL, Park SJ, Shin JY. Lee H, et al. Yonsei Med J. 2019 Jul;60(7):679-686. doi: 10.3349/ymj.2019.60.7.679. Yonsei Med J. 2019. PMID: 31250582 Free PMC article. - Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.
Amegadzie JE, Gamble JM, Farrell J, Gao Z. Amegadzie JE, et al. Int J Chron Obstruct Pulmon Dis. 2022 May 20;17:1205-1217. doi: 10.2147/COPD.S358927. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35645559 Free PMC article. - Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P; Canadian Network for Observational Drug Effect Studies Investigators. Azoulay L, et al. BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581. BMJ. 2016. PMID: 26888382 Free PMC article. - Non-alcoholic fatty liver disease risk with GLP-1 receptor agonists and SGLT-2 inhibitors in type 2 diabetes: a nationwide nested case-control study.
Chang KC, Kuo FC, Yang CY, Yang CT, Ou HT, Kuo S. Chang KC, et al. Cardiovasc Diabetol. 2024 Oct 17;23(1):367. doi: 10.1186/s12933-024-02461-2. Cardiovasc Diabetol. 2024. PMID: 39420429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources